Insulin aspart, recombinant Subcutaneous and Ixazomib Citrate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Ixazomib Citrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ixazomib
Brand name: Ninlaro
Synonyms: Ixazomib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Ixekizumab
- Insulin aspart, recombinant Subcutaneous-Ixekizumab Auto-Injectors
- Insulin aspart, recombinant Subcutaneous-Ixekizumab Prefilled Syringes
- Insulin aspart, recombinant Subcutaneous-Ixekizumab Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Ixempra
- Insulin aspart, recombinant Subcutaneous-Ixempra Kit
- Ixazomib Citrate-Insulin degludec
- Ixazomib Citrate-Insulin Degludec (U-100) Prefilled Pens
- Ixazomib Citrate-Insulin Degludec (U-100) Vials
- Ixazomib Citrate-Insulin Degludec (U-200) Prefilled Pens
- Ixazomib Citrate-Insulin degludec and liraglutide
- Ixazomib Citrate-Insulin degludec and liraglutide Subcutaneous